CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 93 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $91,148,000 | +3.3% | 769,761 | +3.0% | 0.00% | -33.3% |
| Q4 2020 | $88,236,000 | -5.6% | 747,065 | -11.2% | 0.00% | 0.0% |
| Q3 2020 | $93,504,000 | +0.5% | 841,317 | -7.6% | 0.00% | 0.0% |
| Q2 2020 | $93,027,000 | -13.2% | 910,408 | -8.3% | 0.00% | -40.0% |
| Q1 2020 | $107,135,000 | -2.5% | 992,643 | +5.1% | 0.01% | +25.0% |
| Q4 2019 | $109,931,000 | +6.6% | 944,591 | +4.9% | 0.00% | 0.0% |
| Q3 2019 | $103,100,000 | +13.8% | 900,670 | -5.2% | 0.00% | +33.3% |
| Q2 2019 | $90,575,000 | +7.7% | 950,421 | +3.2% | 0.00% | 0.0% |
| Q1 2019 | $84,063,000 | +23.1% | 921,243 | +2.4% | 0.00% | 0.0% |
| Q4 2018 | $68,288,000 | -2.3% | 899,592 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $69,884,000 | -10.1% | 873,552 | +11.6% | 0.00% | 0.0% |
| Q2 2018 | $77,777,000 | +34.8% | 783,020 | +9.9% | 0.00% | 0.0% |
| Q1 2018 | $57,692,000 | +4.7% | 712,244 | +1.8% | 0.00% | +50.0% |
| Q4 2017 | $55,110,000 | +11.3% | 699,628 | +30.4% | 0.00% | 0.0% |
| Q3 2017 | $49,515,000 | – | 536,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |